Post #467371
2026-03-01 09:03 UTC
News-packed update on nextgen Covid vaccines this month at my @PLOS@mstdn.science blog:
- Phase 2 results for a self-amplifying mRNA vaccine from Japan with a phase 3 trial recently closed off
- Preclinical results for an intranasal "universal" vaccine that provided some protection from coronaviruses, H1N1 flu, some bacterial infections, and an asthma allergen
- Opportunities to participate in intranasal vaccine trials in Finland and the US
And much more:
https://absolutelymaybe.plos.org/2026/03/01/progress-for-universal-vaccine-more-nextgen-covid-vax-news-update-no-38/
#Vaccines #Covid #Covid19
Replies (1)
-
@ducky@mstdn.ca 2026-03-02 05:14
@hildabast The Stanford TLR4 agonists/ovalbumin looks incredibly interesting and exciting for limited short-term use, but I worry that causing low-level inflammation long-term would increase the risk of heart disease, diabetes, and cancer. 😠 The Colombia paper on *their* universal vaccine (https://www.science.org/doi/10.1126/scitranslmed.adx5758 ) said that some people who never get sick are missing the ISG15 gene, which gives them low-level inflammation. I know someone who never got sick, and they had *four* totally different cancers before they died. I wonder if they were missing ISG15.